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Background
Specific treatment of opportunistic infections associated
with HIV infection raises real difficulties in current
practice due to side effects, drug interactions and
immune reconstitution syndrome. For advanced immu-
nosuppression initiation of the antiretroviral therapy
may be a therapeutic emergency.
Case report
We present a case of a 29 years old patient, MSM, con-
firmed with HIV infection in 2007 but who do not accept
the diagnosis and returns to our service in 2013. He was
diagnosed with generalized Kaposi sarcoma (extensive skin
lesions, sores in the mouth and cavum, lung injury; the
clinical diagnosis was confirmed by skin biopsy and lung
CT), cerebral toxoplasmosis (specific to brain MRI image
with anti-toxoplasma IgG positive), disseminated tubercu-
losis (positive blood cultures for M tuberculosis) and geni-
tal herpes with large lesions and necrotic component, at a
CD4 = 2 cells/cmm. Treatment was complex, for getting
every opportunistic infection; because of the complexity of
the case and the hematologic associated events (severe leu-
copenia, anemia and thrombocytopenia) has not been dis-
cussed the specific therapy for Kaposi’ sarcoma. After
6 weeks of antinfectious treatment and correction of asso-
ciated metabolic and hematological disorders, the antire-
troviral therapy with Abacavir, Epivir and Raltegravir was
introduced. Without developing immune reconstitution
syndrome the evolution was unfavorable to death.
Conclusion
We discuss the correct therapeutic approach for the treat-
ment of AIDS-defining diseases associated and the proper
management of this type of patient.
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